Characteristics | Re-contact n = 30 | No re-contact n = 74 | Total n = 104 | p-value1 |
History of cancer, n (%) |
|
|
|
|
No history | 12 (40.0) | 34 (45.9) | 46 (44.2) | 0.329b |
Family | 12 (40.0) | 27 (36.5) | 39 (37.5) |
|
Personal | 5 (16.7) | 5 (6.8) | 10 (9.6) |
|
Personal and family | 1 (3.3) | 7 (9.5) | 8 (7.7) |
|
Missing | 0 | 1 (1.3) | 1 (1.0) |
|
Discovery Cancer, n (%) |
|
|
|
|
Systematic screening | 19 (63.3) | 45 (60.8) | 64 (61.5) | 0.407b |
Self discovery | 9 (30.0) | 17 (23.0) | 26 (25.0) |
|
Other | 1 (3.3) | 8 (10.8) | 9 (8.7) |
|
Missing | 1 (3.3) | 4 (5.4) | 5 (4.8) |
|
Surgery, n (%) |
|
|
|
|
Mastectomy | 15 (50.0) | 43 (58.1) | 58 (55.8) | 0.396a |
Tumerectomy | 13 (43.3) | 30 (40.5) | 43 (41.3) |
|
Missing | 2 (6.7) | 1 (1.3) | 3 (2.9) |
|
Additional treatment, n (%) |
|
|
|
|
Chemotherapy + Radiotherapy | 11 (36.7) | 34 (45.9) | 45 (43.3) | 0.327b |
Radiotherapy alone | 9 (30.0) | 26 (35.1) | 35 (33.7) |
|
Chemotherapy alone | 6 (20.0) | 5 (6.8) | 11 (10.6) |
|
Other | 1 (3.3) | 4 (5.4) | 5 (4.8) |
|
None | 2 (6.7) | 3 (4.1) | 5 (4.8) |
|
Missing | 1 (3.3) | 2 (2.7) | 3 (2.9) |
|